Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 76
- Medical
First Khiron specialist medical cannabis clinic opens in Europe
Zerenia Clinics UK is based in London and will be offering in-person and online appointments.
- CBD Market
Setting standards for the UK cannabis industry
The CIC aims to raise the bar for standards in the UK cannabis industry.
- Medical
Eurox begins sale of cannabis products in Germany
Eurox has started the white label sale of its dronabinol products to a number of select customers.
- Medical
Cannabis company receives approval for COVID-19 dose finding study
MGC Pharma has received approval for a dose finding study for its proprietary treatment for the effects of COVID-19.
- Pharmaceutical
UK Cannabis Company’s C-Suite Left ‘Shaking Their Heads’ In Disbelief At Company’s Poor Stock Performance
FOLLOWING its listing on the London Stock Exchange in May this year Oxford Cannabinoid Technologies (OCT) has seen more than £20m wiped off its market capitalisation.
- Hemp Industry
Hemp ‘Fringe’ Festival To Run In Conjunction With Glasgow Climate Talks
A NEW hemp-focused festival, Beyond the Green, is set to be launched alongside the upcoming Cop26 United Nations Climate Change Summit next month.
- Cultivation
GMP certification allows Linneo Health to continue cannabis research
Linneo Health has had its GMP certification renewed for its quality control laboratory and its post-harvest facility.
- Medical
Tilray to supply products for Luxembourg’s medical cannabis programme
Tilray will supply a variety of its pharmaceutical-grade medical cannabis products.
- Pharmaceutical
Oxford Cannabinoid Technologies expects to list on OCT QB in November
Harbour Access has been appointed as North American investor relations advisor to provide support for the listing.
- Companies
Life sciences company to expand into medical cannabis market
Broughton will be focusing on accelerating products to market within strategic markets including the cannabinoids industry.
- Medical
European Medicines Agency gives cannabinoid medicine positive opinion
Tetra Bio-Pharma’s has received a positive opinion from the EMA’s Committee for Orphan Medicinal Products on its application for Orphan Drug Designation for QIXLEEF.
- CBD Market
Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000
THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by around 50 members.
